Intestinal Carcinoma — Trials

Intestinal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,268 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 409
Recruiting: 235
Ph III recruiting: 16
Growth YoY: +6%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (150)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00303628	Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer	terminated	Phase 3	355	ECOG-ACRIN Cancer Research GroupNETWORK	4	Jul 6, 2023	clinicaltrials
NCT03300609	5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab	terminated	Phase 3	4	University of Southern CaliforniaOTHER	1	Jun 11, 2020	clinicaltrials